Dacă - Rudyard Kipling

Dacă - Rudyard Kipling

De poţi să nu-ţi pierzi capul, când toţi în jurul tău
Şi l-au pierdut pe-al lor, găsindu-ţi ţie vină;
De poţi, atunci când toţi te cred nedemn şi rău,
Să nu-ţi pierzi nicio clipă încrederea în tine;

De poţi s-aşepţi oricât, fără să-ţi pierzi răbdarea,
De rabzi să fii minţit, fără ca tu să minţi,
Sau când, hulit de oameni, tu nu cu răzbunarea
Să vrei a le răspunde, dar nici cu rugăminţi;

De poţi visa, dar fără să te robeşti visării,
De poţi gândi, dar fără să-ţi faci din asta un ţel,
De poţi să nu cazi pradă nicicând disperării,
Succesul şi dezastrul primindu-le la fel;

De rabzi s-auzi cuvântul rostit cândva de tine,
Răstălmăcit de oameni, ciuntit şi prefăcut;
De poţi să-ţi vezi idealul distrus, şi din ruine
Să-l reclădeşti cu ardoarea fierbinte din trecut;

De poţi risca pe-o carte întreaga ta avere,
Şi tot ce-ai strâns o viaţă să pierzi într-un minut,
Şi-atunci, fără a scoate o vorbă de durere,
Să-ncepi agoniseala cu calm, de la-nceput;

Şi dacă corpul tău, uzat şi obosit,
Îl vei putea forţa să-ţi mai slujească încă,
Şi numai cu străşnicia voinţei tale,
Să stea peste vreme aşa cum stă o stâncă;

De poţi vorbi mulţimii, fără să minţi,
De poţi sta lângă regi, fără a te-ngânfa,
De, nici amici, nici duşmani, nu pot vreun rău să-ţi facă,
Pentru că doar dreptatea e călăuza ta;

Şi dacă poţi să umpli minuta trecătoare,
Să nu pierzi nicio filă din al vieţii tom,
Al tău va fi pământul, cu bunurile-i toate
Şi, ceea ce-i mai mult chiar, să ştii, vei fi un OM!



Joseph Rudyard Kipling ( * 30 decembrie 1865 Bombay, India - † 18
ianuarie, 1936 ) poet şi prozator britanic, laureat al Premiului Nobel
pentru Literatură în anul 1907. Este celebru prin povestirea sa pentru
copii „Cartea Junglei" (1894), romanul indian de spionaj „Kim" (1901),
poemele „Gunga Din" (1892) şi „If" (1895), numeroase schiţe şi
nuvele.
În 1934 i s-a acordat, alături de William Butler Yeats, Premiul
Gothenburg pentru Poezie. În timpul vieţii, a fost considerat,
îndeobşte poet şi i s-a oferit un titlu nobiliar şi postul de poet
laureat ambele refuzate de Kipling.

Poezia „Dacă" este considerată de mulți ca fiind una dintre cele mai
frumoase poezii ale lumii, ea reprezentând un fel de Ghid pentru
cizelarea și șlefuirea ființei umane.

Editorial Noiembrie 2012 - Prof.Dr.Aurel ROMILA

PARANOIDIE

Din primii ani de psihiatrie am retinut distinctia dintre sindromul depresiv, ca auto-acuzare si sindromul paranoid ca hetero-acuzare. Practic l-am inteles cind un subaltern m-a acuzat ca il persecut, cind, in realitate, nu-i facusem niciun rau. Am avut atunci intuitia esentei psihiatriei, persecutia imaginara, durerea PENTRU CEL CE O SIMTE SI PENIBILA suferinta PENTRU CEL ACUZAT CARE NU STIE CUM SA SE APERE SI SA DOVEDEASCA ADEVARUL.

Se creaza o ruptura intre persecutat si persecutor. Pot fi si urmari seioase.

In practica, auzim multe persecutii. Nu toate sunt delirante, patologice, imaginare. Experienta ne invata sa discernem persecutiile patologice de cele reale. In definitiv, orice om este in viata lui cel putin citeodata persecutat. Toate nedreptatile sunt persecutii. Cind la scoala pune pe unul mai prost inaintea ta, cind meritele le iau altii, cind contributiile sunt minimalizate sau ignorate, cind esti acuzat pe nedrept, sau faci puscarie pe nedrept, reabilitarile ulterioare sunt iluzorii. Persecutie este si stigmatizarea bolnavului mintal, desi nu toti sunt inferiori persecutorului. Toate superioritatile neintemeiate, toate incompetentele, toate monopolurile sunt distinctii persecutorii pentru umilirea nedreapta a oamenilor.
Asa ca, desi cel mai frecvent sindrom din psihiatrie este sindromul depresiv, cel mai periculos si mai greu de tratat este sindromul paranoid. Este greu de tratat. Nu poate fi negat direct,dar psihoterapia incearca toleranta iar terapia religioasa cere chiar iertarea.

Este important nu numai pentru psihiatru si psiholog ci si pentru oamenii dreptului, politie, autoritati sa cunoasca aceasta desosebire intre persecutia imaginara si cea reala.

Prof.Dr.Aurel ROMILA

Fwd: The British Journal of Psychiatry Highlights of this issue for 1 November 2012; Vol. 201, No. 5

BJP Online -- Highlights of the Current Issue

November 2012; Vol. 201, No. 5

The complete Table of Contents for the current issue is available online at: http://bjp.rcpsych.org/content/vol201/issue5/ The following content is available online at: http://bjp.rcpsych.org/cgi/content/full/201/5/A19

Highlights of this issue

Sukhwinder S. Shergill Depression, fitness and vitamin D
Increased levels of physical exercise have been related to improvements in cognitive functioning and mood in patients with depression. The evidence for sedentary lifestyle and low levels of physical activity in early adulthood being associated with subsequent depressive symptoms is more mixed.Å_berg and colleagues (pp. 352–359) examined depressive illness in a large cohort of prospectively assessed male army conscripts, and found that lower cardiovascular fitness at age 18 was a risk for serious depressive illness in later life. They propose that their data offer support for intervening in high-risk groups and also encourage further research into the biochemical consequences of enhanced cardiovascular fitness. An accompanying editorial suggests that depression and cardiovascular disease should no longer be conceptualised as separate entities, but more as intertwined and interrelated diseases, which needs to be re flected in their treatment. De Jonge & Roest (pp. 337–338) suggest that this interaction focuses attention upon the need for personalised medicine, where lifestyle interventions such as exercise may benefit both depression and cardiovascular disease through positive change in their common mediating factors. Vitamin D deficiency is another factor that has been linked with depressive illness through epidemiological studies. Kjærgaard and colleagues (pp. 360–368) replicated the finding of increased depressive symptoms being associated with lower levels of baseline 25-hydroxyvitamin D, but found no change in these symptoms after treatment with high-dose vitamin D for 6 months. They suggest that this indicates that low vitamin D levels are likely to arise as a consequence of depressive symptoms rather than vice versa. However, they acknowledge that they cannot exclude t he possibility that this lack of treatment response may be an artefact of not including participants with high rates of depressive symptoms in their sample, inadvertently lowering the threshold for a placebo response. An editorial by Berk & Jacka (pp. 339–341) reviews the difficulty of studies examining risk factors for complex disorders such as depression, but concords with de Jonge & Roest that mental and physical illness and lifestyle are all implicated in complex illness, and that lifestyle may form the common denominator, suggesting a greater focus on lifestyle modification as a component of prevention of psychiatric disorders.
Anorexia, bipolar disorder and refractory depression
Anorexia nervosa continues to carry a high level of morbidity and while psychological approaches are the treatment of choice, there is no clear gold standard of psychological therapy. A trial comparing two different out-patient based psychological treatments failed to find any significant between-group difference in primary outcomes, but both groups improved from baseline, although there were no improvements in neuropsychological variables. Schmidt and colleagues (pp. 392–399) suggest the positives are that both the treatments were beneficial for patients, and the strengths of the design – with randomised therapists, and patients recruited from real-life busy clinical practice – means the results are likely to be robust. Similar to anorexia, there is evidence that subsequent episodes in bipolar disorder may be more difficult to treat. However, this may be confounded by data suggesting that longer-term antidepressant therapy may increase affective instability over time. Tohen et al (pp. 376–382) demonstrate that olanzapine monotherapy may offer an alternative therapeutic option; it was efficacious in a 6-week placebo-controlled study in bipolar depression. They comment on the limitations of this short-term study and highlight the need to monitor safety very carefully. Depression that is refractory to treatment poses considerable clinical and social difficulties. There may be value in specialist care for such disorders; Fekadu and colleagues (pp. 369–375) report on the outcomes of their specialist affective disorders service – 48% of their patients showed sustained remission lasting at least 6 months. They report that severity of treatment-resistant depression, educational level and extent of social support were important factors associated with sustained improvement. There was als o a possibility that monoamine oxidase inhibitors and duloxetine may be more useful in this group with difficult-to-treat illness.
Dementia care and connectivity in psychopathy
Dementia is a common and distressing condition, and coexisiting psychiatric and behavioural symptoms are problematic, with significant concerns over antipsychotic prescriptions. Psychosocial interventions have been shown to benefit these symptoms, but implementation has been patchy across different services with little systematic research on their acceptability. Lawrence and colleagues (pp. 344–351) describe a meta-synthesis of the qualitative literature, which identified the importance of individualised interventions tailored to the person, and the full support of care staff in residential settings. Barriers to implementation include pressure on staff time, a focus on priority needs and a preoccupation with risk. They suggest that quantitative and qualitative research need to be combined to show not only what works, but also how and why it works. Orrell (pp. 342–343) places these findings within a wider context in an accompanying editorial, highlighting the promising progress made in applying psychosocial interventions to dementia care. He also points out the obstacles preventing systematic implementation of psychosocial approaches, including the lack of formal manualised training and lack of ongoing resource to support care.

JSPN 109th meeting : Abstract submission now open

Dear International Colleagues


With pleasure I announce that the abstract submission for the 109th
Japanese Society of Psychiatry and Neurology is now open.

http://www.jspn109.org/jspn109-web-eng/call_for_abstract_eng/index.html


The deadline is 15 November 2012. I look forward to receiving active
submissions from the world.
Sincerely yours,
October, 2012
Shigenobu Kanba
President of the 109th Annual Meeting of Japanese Society of
Psychiatry and Neurology Chairman, Neuropsychiatry, Kyushu University